KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Non Operating Investment Income: 2016-2023

Historic Non Operating Investment Income for CareDx (CDNA) over the last 6 years, with Jun 2023 value amounting to $3,000.

  • CareDx's Non Operating Investment Income fell 93.75% to $3,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $42,000, marking a year-over-year decrease of 80.82%. This contributed to the annual value of $2.1 million for FY2023, which is 1871.03% up from last year.
  • Per CareDx's latest filing, its Non Operating Investment Income stood at $3,000 for Q2 2023, which was down 57.14% from $7,000 recorded in Q1 2023.
  • CareDx's 5-year Non Operating Investment Income high stood at $4.3 million for Q3 2019, and its period low was -$3.0 million during Q1 2019.
  • Moreover, its 3-year median value for Non Operating Investment Income was $22,500 (2021), whereas its average is $22,300.
  • In the last 5 years, CareDx's Non Operating Investment Income slumped by 251.65% in 2020 and then skyrocketed by 173.85% in 2022.
  • Quarterly analysis of 5 years shows CareDx's Non Operating Investment Income stood at $333,000 in 2019, then crashed by 251.65% to -$505,000 in 2020, then soared by 111.09% to $56,000 in 2021, then slumped by 67.86% to $18,000 in 2022, then plummeted by 93.75% to $3,000 in 2023.
  • Its Non Operating Investment Income stands at $3,000 for Q2 2023, versus $7,000 for Q1 2023 and $18,000 for Q4 2022.